Table 5. Outcomes At Discharge And At 6 Months.

	Secondary hospitals n = 43 (%)	TBH n = 33 (%)	p-value
At Discharge
Mortality	10 (23)	2 (6)	0.0326*
Discharge medications (% of survivors)
Asprin	31 (94)	30 (97)	0.5918
β-blocker	29 (88)	30 (97)	0.1851
ACE inhibitor	25 (76)	26 (84)	0.4201
ARB	1 (3)	2 (6)	0.5175
Statin	30 (91)	29 (94)	0.6942
Spironolactone	3 (9)	2 (6)	0.6942
Clopidogrel	8 (24)	9 (29)	0.6646
Days in hospital (± SD) (% of survivors)	6.14 (± 4.33)	5.82 (± 5.26)	0.2100
At 6 months
Survived (expressed as % of entire group)	29 (73)	27 (90)	0.0614
Survived (expressed as % of survivors at discharge)	29 (97)	27 (96)	0.9247
Chest pain (% of survivors at 6 months)
None	17 (59)	16 (59)	0.6206
Occasional	9 (31)	10 (37)	0.8540
CCS 2	2 (7)	1 (4)	0.5960
CCS 3	1 (3)	0.(0)	0.3302
Readmission to hospital (% of survivors at 6 months)	9 (31)	4 (15)	0.1461
Subsequent angiography (% of survivors at 6 months)	6 (21)	3 (11)	0.3248
Time from admission (months)	3.86 (± 2.07)	1.33 (± 0.58)	0.0121*
Coronary revascularisation within 6 months (n = 43 and 33)	19 (44)	28 (85)	0.0001*

CCS: Canadian Cardiovascular Society angina classification

*p-values calculated comparing TBH and secondary hospital groups, p < 0.05 was statistically significant.